John H. Healey, MD, FACS
Chief, Orthopaedic Service; Stephen McDermott Chair in Surgery
Bone and Soft Tissue Sarcoma; Benign Bone Tumors; Prosthetic Reconstruction; Metabolic Bone Disease; Pediatric Sarcomas
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Healey accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
In New York State
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York HMO, EPO, PPO, and POS plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Memorial Sloan Kettering is not an in-network provider for Empire's Medicare Managed Care plan known as Mediblue).
- Memorial Sloan Kettering is a designated Center of Excellence by Blue Cross Blue Shield.
In New Jersey
Memorial Sloan Kettering is an in-network provider with some Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. For example, the PPO plan is in-network with our Manhattan locations.
Horizon Blue Cross HMO is only in-network with our Basking Ridge, Bergen and Monmouth locations. It does not allow access to our Manhattan facilities.
Horizon Blue Cross PPO is in network with our Basking Ridge, Bergen, Monmouth and Manhattan locations.
OMNIA Plans: Tier I EPO based plan policy is only in-network with our Basking Ridge, Bergen and Monmouth locations and does not allow access to our Manhattan sites. Tier II EPO is only in-network with our Manhattan sites if it is a blue-card plan (there would be a suitcase logo indicating PPO on the front of the card).
Other plans may only be in-network at our Basking Ridge, Bergen or Monmouth locations.
Outside New York State and New Jersey
Some, but not all, Blue Cross Blue Shield plans outside of New York and New Jersey include Memorial Sloan Kettering as an in-network provider. Contact your insurance to find out if your plan provides in-network access to Memorial Sloan Kettering.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans and Medicare plans. Emblem Health does not include us in any of its Select Care network plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment.
Formerly known as Health Plus Amerigroup, Empire Blue Cross Blue Shield Health Plus is an in-network provider with Memorial Sloan Kettering. You will need a one-time referral from your primary care doctor.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with Medicaid NY Empire Blue Cross Blue Shield HealthPlus (formerly known as Amerigroup). You will need a one-time referral from your primary care doctor.
In New York: Memorial Sloan Kettering’s New York locations are in-network with the Emblem
In New Jersey: Memorial Sloan Kettering’s New Jersey locations in Basking Ridge, Bergen and Monmouth are in-network with the Horizon Medicare Advantage Plan. This plan is not accepted for care provided at MSK’s New York locations.
If you are enrolled in any other Medicare Advantage plan, please contact your insurance carrier to determine your benefits and coverage at Memorial Sloan Kettering since your access may be limited.
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.
MD, University of Vermont College of Medicine
General Surgery - Tufts-New England Medical Center; Orthopaedic Surgery - Hospital for Special Surgery
Musculoskeletal Oncology - Memorial Sloan Kettering Cancer Center; Metabolic Bone Disease - Hospital for Special Surgery
I am an orthopaedic surgeon who specializes in caring for people with sarcomas and noncancerous tumors of the bones and soft tissue. I have particular expertise in removing tumors while preserving limbs. I also have a special interest in treating children who have bone cancers, such as osteosarcoma and Ewing sarcoma. I have been at MSK since 1984 and perform approximately 260 surgeries each year.
I was inspired to find my calling to help those with cancers of the musculoskeletal system after losing a dear friend to sarcoma when I was in high school. Today, I’m proud to be part of a team whose missionary zeal is to treat people with these diseases and help them continue to have productive lives.
Limb reconstruction has become an important part of treatment. My expertise includes rebuilding bones and joints with bone transplants and joint replacements. I perform limb-preserving surgeries and customized techniques to restore function using biologic and synthetic materials. Our goal is always to cure a patient’s cancer, but we strive to understand each person’s lifestyle too. We want to help them continue to do the things they love and maintain hope for their future.
My research involves understanding the molecular biology of sarcoma, developing new ways to deliver chemotherapy to tumors, and improving the durability and function of joint replacements. I have invented four joint replacement systems. I have patented several methods to deliver drugs to tumors. I also lead clinical investigations of different surgical reconstructions, 3-D printed implants, and methods to minimize surgical complications. My laboratory research explores ways to use the immune system and tumor environment to kill cancer.
In addition to my role as Chief of the Orthopaedic Service at MSK, I am a professor of orthopaedic surgery at Weill Cornell Medical College. Nationally, I have served as chair of the Children’s Oncology Group Orthopaedics Section, president of the International Society of Limb Salvage, and president of the Association of Bone and Joint Surgeons, as well as on the boards of several musculoskeletal and orthopaedic organizations. I am an advisor to the National Comprehensive Cancer Network.
Education is also an important part of my job. I served as Vice Chair of Conferences and Education for MSK’s Department of Surgery. I directed the Orthopaedics Fellowship Program at MSK for 20 years and am proud to have trained leading specialists in this field in North and South America, Europe, and Asia. Most importantly, I educate my patients about their disease and how we will creatively and effectively meet their needs. It gives them hope and resolve to confront this rare diagnosis.
My academic career has allowed me to spend time abroad. I was the first American traveling fellow in Japan, and I studied at the Karolinska Institute in Stockholm.
I played baseball in college and continue to love and follow the game.
Awards and Honors
- Castle Connolly: New York Magazine Top Doctors (2002–2020)
- the Sarcoma Foundation of America’s Nobility in Science Award
- inaugural recipient of the Dominican Health Care Ministry of New York’s Spe Salvi Award
- Clinical Trials Investigated by Dr. Healey
- A Study Assessing Patients' Quality of Life and Function after Different Types of Surgery for Cancer in the Femur (Thighbone)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Diagnosis and Management of Pathologic Fractures. Lane JM, Healey JH, eds. New York, NY: Raven Press; 1993.
Selected Book Chapters
“Bone tumors.” Healey JH. In Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 16th ed. Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL, eds. Philadelphia, PA: WB Saunders; 2001: 519-532.
“Bone and soft tissue tumors around the knee.” Healey JH. In Surgery of the Knee. 3rd ed. Insall JN, Scott WN, eds. New York, NY: Churchill Livingstone; 2001: 1997-2028.
“Sarcomas of bone.” Lin PP, Healey JH. In: Surgical Oncology. Bland KI, Daly JM, Karakousis CP, eds. New York, NY: McGraw-Hill; 2001: 1015-1053.
“Bone and soft tissue tumors about the knee.” Healey JH, Kennedy JG. In: The Adult Knee. Callaghan JJ, Rosenberg AG, Rubash HE, Simonian PT, Wickiewicz TL, eds. Philadelphia, PA: Lippincott Williams & Wilkins; 2003: 495-520.
“Soft tissue sarcomas and bone tumors.” Healey JH. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 17th ed. Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL, eds. Philadelphia, PA: Saunders; 2004: 815-832.
“Metastatic cancer to the bone.” Manoso MM, Healey JH. In: Cancer: Principles and Practice of Oncology. 7th ed. DeVita VT Jr, Hellman S, Rosenberg SA, eds. Philadelphia, PA: Lippincott Williams & Wilkins; 2005: 2368-2380.
“Bone tumors.” Nathan SS, Healey JH. In: Pediatric Surgery. 6th ed. Grosfeld JL, O’Neill JA Jr, Fonkalsrud EW, Coran AG, eds. Philadelphia, PA: Mosby; 2006: 649-670.
“Cancer pain management in orthopedic surgery.” Healey JH. In: Encyclopedia of Pain. Schmidt RF, Willis WD, eds. Berlin, Germany: Springer-Verlag; 2007: 359-361.
“The role of orthopaedic surgery in the palliative care of patients with cancer.” Healey JH, Tyler WK. In: Oxford Textbook of Palliative Medicine. 4th ed. Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK, eds. New York, NY: Oxford University Press; 2009: 558-572.
“Bone tumors.” Nathan SS, Healey JH. In: Pediatric Surgery. 7th ed. Coran AG, Adzick NS, Krummel TM, Laberge JM, Shamberger RC, Caldamone AA, eds. Philadelphia, PA: Elsevier Saunders; 2012: 577-590.
Visit PubMed for a full listing of Dr. Healey’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
John H. Healey discloses the following relationships and financial interests:
Musculoskeletal Transplant Foundation
Fiduciary Role/Position; Provision of Services
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.